<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Dengue virus infection: Clinical manifestations and diagnosis</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Dengue virus infection: Clinical manifestations and diagnosis</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Dengue virus infection: Clinical manifestations and diagnosis</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Stephen J Thomas, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Alan L Rothman, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Anon Srikiatkhachorn, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Siripen Kalayanarooj, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Martin S Hirsch, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Keri K Hall, MD, MS</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Oct 05, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Dengue is a febrile illness caused by infection with one of four dengue viruses (DENV) transmitted by <em>Aedes aegypti</em> or <em>Aedes</em> <em>albopictus</em> mosquitoes during the taking of a blood meal [<a href="#rid1">1-3</a>]. Infection may be asymptomatic or present with a broad range of clinical manifestations including a mild febrile illness to a life-threatening shock syndrome. Numerous viral, host, and vector factors are thought to impact risk of infection, disease, and disease severity.</p><p>There are four closely related but serologically distinct DENV types of the genus <em>Flavivirus</em>, called DENV-1, DENV-2, DENV-3, and DENV-4. There is transient cross-protection among the four DENVs, which weakens and disappears over the months following infection; therefore, individuals living in a dengue-endemic area with all types co-circulating are at risk for infection with any and all DENV types. </p><p>Issues related to clinical manifestations and diagnosis of DENV infection will be reviewed here. Issues related to epidemiology, pathogenesis, prevention, and treatment are discussed separately. (See  <a class="medical medical_review" href="/d/html/3029.html" rel="external">"Dengue virus infection: Pathogenesis"</a> and  <a class="medical medical_review" href="/d/html/3030.html" rel="external">"Dengue virus infection: Prevention and treatment"</a> and  <a class="medical medical_review" href="/d/html/3028.html" rel="external">"Dengue virus infection: Epidemiology"</a>.)</p><p class="headingAnchor" id="H3997742967"><span class="h1">CLASSIFICATION SCHEMES</span></p><p class="headingAnchor" id="H806351449"><span class="h2">Overview</span><span class="headingEndMark"> — </span>In 1997, the World Health Organization (WHO) published a classification scheme describing three categories of symptomatic DENV infection: dengue fever (DF), dengue hemorrhagic fever (DHF), and dengue shock syndrome (DSS) [<a href="#rid4">4</a>]. (See <a class="local">'WHO 1997 classification'</a> below.)</p><p>The WHO 1997 classification scheme is data driven and evidence based but has been criticized [<a href="#rid5">5</a>]. The term DHF suggests that hemorrhage is the cardinal manifestation of severe dengue; however, plasma leakage leading to intravascular volume depletion and potentially shock is the most specific feature of severe dengue and the focus of clinical management guidelines and algorithms [<a href="#rid6">6,7</a>]. In addition, some patients with severe illness requiring medical intervention do not meet all criteria for DHF. It is generally believed that use of the 1997 WHO definition for DHF underestimates the clinical burden of infection [<a href="#rid8">8</a>].</p><p>In response to a wide call to reevaluate dengue disease classification, in 2009 the WHO published a revised classification scheme describing the following categories: dengue without warning signs, dengue with warning signs, and severe dengue [<a href="#rid9">9</a>] (see <a class="local">'WHO 2009 classification'</a> below). This scheme was proposed to emphasize early recognition of warning signs and thus optimize triage and management decisions. It has been adopted for case reporting and clinical management in many but not all countries. The sensitivity and specificity of the categories in the 2009 scheme for guiding clinical management of patients are not known. The 2009 classification has, in turn, been criticized for a lack of clarity in the criteria for severe dengue and for obscuring distinct disease phenotypes within each category [<a href="#rid10">10</a>].</p><p>In 2011, the WHO South-East Asia Regional Office published new guidelines for the prevention and control of dengue and introduced the concept of the expanded dengue syndrome. The syndrome includes patients with severe organ involvement (liver, kidney, brain, or heart) but without evidence of plasma leakage. Prolonged shock, comorbidities, and/or coinfections were cited as common risk factors [<a href="#rid11">11</a>]. </p><p>Dengue classification schemes support a range of activities from clinical triage and treatment to epidemiologic and vaccine and drug studies. Each guideline has been evaluated by a number of groups, and the 2009 classification has not superseded the 1997 classification for all aspects of DENV infection [<a href="#rid12">12-16</a>]. The WHO issued additional documents on dengue management in 2011 and 2012 [<a href="#rid17">17,18</a>].</p><p class="headingAnchor" id="H3996738437"><span class="h2">WHO 1997 classification</span><span class="headingEndMark"> — </span>In 1997, the WHO published a classification scheme describing three categories of symptomatic infection: DF, DHF, and DSS [<a href="#rid4">4</a>]. (See <a class="local">'Classification schemes'</a> above.)</p><p class="headingAnchor" id="H1647699899"><span class="h3">Dengue fever</span><span class="headingEndMark"> — </span>DF (also known as "break-bone fever") is an acute febrile illness defined by the presence of fever and two or more of the following but not meeting the case definition of DHF [<a href="#rid4">4</a>] (see <a class="local">'Dengue hemorrhagic fever'</a> below):</p><p class="bulletIndent1"><span class="glyph">●</span>Headache</p><p class="bulletIndent1"><span class="glyph">●</span>Retro-orbital or ocular pain</p><p class="bulletIndent1"><span class="glyph">●</span>Myalgia and/or bone pain</p><p class="bulletIndent1"><span class="glyph">●</span>Arthralgia</p><p class="bulletIndent1"><span class="glyph">●</span>Rash</p><p class="bulletIndent1"><span class="glyph">●</span>Hemorrhagic manifestations (eg, positive tourniquet test, petechiae, purpura/ecchymosis, epistaxis, gum bleeding, blood in emesis, urine, or stool, or vaginal bleeding)</p><p class="bulletIndent1"><span class="glyph">●</span>Leukopenia</p><p></p><p class="headingAnchor" id="H129991018"><span class="h3">Dengue hemorrhagic fever</span><span class="headingEndMark"> — </span>The cardinal feature of DHF is plasma leakage due to increased vascular permeability as evidenced by hemoconcentration (≥20 percent rise in hematocrit above baseline), pleural effusion, or ascites [<a href="#rid4">4</a>]. DHF is also characterized by fever, thrombocytopenia, and hemorrhagic manifestations (all of which may also occur in the setting of DF) [<a href="#rid4">4</a>]. (See <a class="local">'Dengue fever'</a> above.)</p><p>In the setting of DHF, the presence of intense abdominal pain, persistent vomiting, and marked restlessness or lethargy, especially coinciding with defervescence, should alert the clinician to possible impending DSS [<a href="#rid19">19</a>]. (See <a class="local">'Dengue shock syndrome'</a> below.)</p><p>The criteria for DHF comprise a narrow definition that does not encompass all patients with clinically severe or complicated DENV infections [<a href="#rid5">5,20</a>]. (See <a class="local">'Classification schemes'</a> above.)</p><p>According to the guidelines, a DHF diagnosis requires all of the following be present:</p><p class="bulletIndent1"><span class="glyph">●</span>Fever or history of acute fever lasting 2 to 7 days, occasionally biphasic</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Hemorrhagic tendencies evidenced by at least one of the following:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>A positive tourniquet test – The tourniquet test is performed by inflating a blood pressure cuff on the upper arm to a point midway between the systolic and diastolic pressures for 5 minutes. A test is considered positive when 10 or more petechiae per 2.5 cm (1 inch) square are observed. The test may be negative or mildly positive during the phase of profound shock. It usually becomes positive, sometimes strongly positive, if the test is conducted after recovery from shock. It is estimated that the tourniquet test is positive in 80 percent of patients with dengue [<a href="#rid7">7</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Petechiae, ecchymoses, or purpura.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Bleeding from the mucosa, gastrointestinal tract, injection sites, or other locations.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Hematemesis or melena.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Thrombocytopenia (100,000 cells per mm<sup>3</sup> or less) – This number represents a direct count using a phase-contrast microscope (normal is 200,000 to 500,000 per mm<sup>3</sup>). In practice, for outpatients, an approximate count from a peripheral blood smear is acceptable. In healthy individuals, 4 to 10 platelets per oil-immersion field (100x; the average of the readings from 10 oil-immersion fields is recommended) indicates an adequate platelet count. An average of 3 platelets per oil-immersion field is considered low (ie, 100,000 per mm<sup>3</sup>).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Evidence of plasma leakage due to increased vascular permeability manifested by at least one of the following:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>A rise in the hematocrit equal to or greater than 20 percent above average for age, sex, and population.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>A drop in the hematocrit following volume-replacement treatment equal to or greater than 20 percent of baseline.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Signs of plasma leakage such as pleural effusion, ascites, and hypoproteinemia.</p><p></p><p class="headingAnchor" id="H2113002363"><span class="h3">Dengue shock syndrome</span><span class="headingEndMark"> — </span>DSS is DHF with marked plasma leakage that leads to circulatory collapse (shock) as evidenced by narrowing pulse pressure or hypotension  (<a class="graphic graphic_table graphicRef109848" data-inline-graphics="109848" href="/d/graphic/109848.html" rel="external">table 1</a>).</p><p>For a diagnosis of DSS, all of the above four criteria for DHF must be present plus evidence of circulatory failure manifested by:</p><p class="bulletIndent1"><span class="glyph">●</span>Rapid and weak pulse.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Narrow pulse pressure (20 mmHg [2.7 kPa]) or manifested by:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Hypotension for age – Hypotension is defined to be a systolic pressure 80 mmHg (10.7 kPa) for those less than 5 years of age or 90 mmHg (12.0 kPa) for those greater than or equal to 5 years of age. Note that narrow pulse pressure is observed early in the course of shock, whereas hypotension is observed later or in patients who experience severe bleeding.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Cold, clammy skin and restlessness.</p><p></p><p class="headingAnchor" id="H3426361982"><span class="h2">WHO 2009 classification</span><span class="headingEndMark"> — </span>In 2009, the WHO introduced a revised classification scheme consisting of the following categories: dengue without warning signs, dengue with warning signs, and severe dengue [<a href="#rid9">9</a>]. (See <a class="local">'Classification schemes'</a> above.)</p><p class="headingAnchor" id="H2802103392"><span class="h3">Dengue without warning signs</span><span class="headingEndMark"> — </span>A presumptive diagnosis of dengue infection may be made in the setting of residence in or travel to an endemic area plus fever and two of the following [<a href="#rid9">9</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Nausea/vomiting</p><p class="bulletIndent1"><span class="glyph">●</span>Rash</p><p class="bulletIndent1"><span class="glyph">●</span>Headache, eye pain, muscle ache, or joint pain</p><p class="bulletIndent1"><span class="glyph">●</span>Leukopenia</p><p class="bulletIndent1"><span class="glyph">●</span>Positive tourniquet test</p><p></p><p>These clinical manifestations are described further above. (See <a class="local">'Dengue fever'</a> above.)</p><p class="headingAnchor" id="H3614769352"><span class="h3">Dengue with warning signs</span><span class="headingEndMark"> — </span>Dengue with warning signs of severe infection includes dengue infection as defined above in addition to any of the following [<a href="#rid9">9</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Abdominal pain or tenderness</p><p class="bulletIndent1"><span class="glyph">●</span>Persistent vomiting</p><p class="bulletIndent1"><span class="glyph">●</span>Clinical fluid accumulation (ascites, pleural effusion)</p><p class="bulletIndent1"><span class="glyph">●</span>Mucosal bleeding</p><p class="bulletIndent1"><span class="glyph">●</span>Lethargy or restlessness</p><p class="bulletIndent1"><span class="glyph">●</span>Hepatomegaly &gt;2 cm</p><p class="bulletIndent1"><span class="glyph">●</span>Increase in hematocrit concurrent with rapid decrease in platelet count</p><p></p><p>Issues related to plasma leakage are described further above. (See <a class="local">'Dengue hemorrhagic fever'</a> above.)</p><p class="headingAnchor" id="H3235950633"><span class="h3">Severe dengue</span><span class="headingEndMark"> — </span>Severe DENV infection includes infection with at least one of the following [<a href="#rid9">9</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Severe plasma leakage leading to:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Shock</p><p class="bulletIndent2"><span class="glyph">•</span>Fluid accumulation with respiratory distress</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Severe bleeding (as evaluated by clinician)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Severe organ involvement:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Aspartate aminotransferase (AST) or alanine aminotransferase (ALT) ≥1000 units/L</p><p class="bulletIndent2"><span class="glyph">•</span>Impaired consciousness</p><p class="bulletIndent2"><span class="glyph">•</span>Organ failure</p><p></p><p class="headingAnchor" id="H3"><span class="h1">CLINICAL MANIFESTATIONS</span></p><p class="headingAnchor" id="H3572064596"><span class="h2">General principles</span><span class="headingEndMark"> — </span>It is estimated that over 390 million DENV infections occur each year; approximately 96 million are clinically apparent [<a href="#rid21">21</a>]. </p><p>Clinically apparent dengue is more common among adults [<a href="#rid22">22</a>]; among children, most infections are asymptomatic or minimally symptomatic [<a href="#rid23">23,24</a>]. In one study including more than 3400 children in Southeast Asia and Latin America with acute febrile illness, dengue accounted for approximately 10 percent of cases; the incidence of virologically confirmed DENV infection was 4.6 and 2.9 episodes per 100 person-years, respectively, and the incidence of dengue hemorrhagic fever (DHF) was &lt;0.3 episodes per 100 person-years [<a href="#rid25">25</a>].</p><p>A primary DENV infection is the first wild-type infection an individual sustains; a secondary infection is the second wild-type infection caused by a different DENV type. Secondary infections separated in time by more than 18 months represent the highest risk for resulting in a severe clinical outcome [<a href="#rid20">20,26,27</a>]. (See <a class="local">'Severe dengue'</a> above.)</p><p>The incubation period of DENV infection ranges from 3 to 14 days; symptoms typically develop between 4 and 7 days after the bite of an infected mosquito [<a href="#rid28">28</a>].</p><p>Patients with suspected dengue should be assessed carefully and directed to the appropriate care setting. Early recognition of progression to severe disease and patients at increased risk for severe disease is essential, with prompt initiation of more aggressive therapy when necessary. (See  <a class="medical medical_review" href="/d/html/3030.html" rel="external">"Dengue virus infection: Prevention and treatment"</a>.)</p><p class="headingAnchor" id="H2508477551"><span class="h2">Phases of infection</span><span class="headingEndMark"> — </span>There are three phases that can be seen in the setting of DENV infection: a febrile phase, a critical phase, and a recovery phase; however, the critical phase is not seen in all categories of infection [<a href="#rid9">9</a>]. The phases of infection are described further in the sections below.</p><p>Within the WHO 1997 classification scheme, all three phases of infection occur in the setting of DHF and dengue shock syndrome; dengue fever (DF) includes febrile and recovery phases but no critical phase [<a href="#rid9">9</a>]. (See <a class="local">'WHO 1997 classification'</a> above.)</p><p>Within the WHO 2009 classification scheme, all three phases of infection occur in the setting of severe dengue and dengue with warning signs; dengue without warning signs includes febrile and recovery phases but no critical phase. (See <a class="local">'WHO 2009 classification'</a> above.)</p><p>Issues related to the WHO classification schemes are discussed further above. (See <a class="local">'Classification schemes'</a> above.)</p><p class="headingAnchor" id="H2430841706"><span class="h3">Febrile phase</span><span class="headingEndMark"> — </span>The febrile phase of DENV infection is characterized by sudden high-grade fever (≥38.5°C) accompanied by headache, vomiting, myalgia, arthralgia, and a transient macular rash in some cases [<a href="#rid28">28-30</a>]. Children have high fever but are generally less symptomatic than adults during the febrile phase. The febrile phase lasts for three to seven days, after which most patients recover without complications.</p><p>Headache, eye pain (ie, pain with eye movement), and joint pain occur in 60 to 70 percent of cases [<a href="#rid24">24</a>]. Rash occurs in approximately half of cases; it is more common during primary infection than secondary infection. When present, rash generally occurs two to five days after the onset of fever [<a href="#rid24">24</a>]. It is typically macular or maculopapular and may occur over the face, thorax, abdomen, and extremities; it may be associated with pruritus  (<a class="graphic graphic_picture graphicRef97534" data-inline-graphics="97534" href="/d/graphic/97534.html" rel="external">picture 1</a> and <a class="graphic graphic_picture graphicRef97996" data-inline-graphics="97996" href="/d/graphic/97996.html" rel="external">picture 2</a>). Additional manifestations may include gastrointestinal symptoms (including anorexia, nausea, vomiting, abdominal pain, and diarrhea) and respiratory tract symptoms (cough, sore throat, and nasal congestion).</p><p>Hemorrhagic manifestations may be observed in the febrile phase and/or critical phase (see <a class="local">'Critical phase'</a> below). The range and severity of hemorrhagic manifestations are variable [<a href="#rid5">5,7,31</a>]. Major skin and/or mucosal bleeding (gastrointestinal or vaginal) may occur in adults with no obvious precipitating factors and only minor plasma leakage. In children, clinically significant bleeding occurs rarely, usually in association with profound and prolonged shock. Two Cuban studies noted spontaneous petechiae or ecchymoses in approximately half of patients [<a href="#rid32">32,33</a>]. Other less frequent manifestations included hematemesis (15 to 30 percent), heavy menstrual bleeding (40 percent of women), melena (5 to 10 percent), epistaxis (10 percent), or hematuria [<a href="#rid34">34</a>]. Comorbid or pre-existing medical conditions (such as peptic ulcer disease) may increase the risk for hemorrhage. Significant thrombocytopenia is not always present when hemorrhagic manifestations occur; when present, it increases the risk of hemorrhage. </p><p>Physical examination may demonstrate conjunctival injection, pharyngeal erythema, lymphadenopathy, and hepatomegaly [<a href="#rid29">29</a>]. Facial puffiness, petechiae (on the skin and/or palate), and bruising (particularly at venipuncture sites) may be observed [<a href="#rid35">35</a>]. A tourniquet test should be performed by inflating a blood pressure cuff on the arm to midway between systolic and diastolic blood pressures for five minutes [<a href="#rid31">31,36</a>]. The skin below the cuff is examined for petechiae one to two minutes after deflating the cuff; presence of 10 or more new petechiae in one square inch area is considered a positive test  (<a class="graphic graphic_picture graphicRef97567" data-inline-graphics="97567" href="/d/graphic/97567.html" rel="external">picture 3</a>).</p><p>A biphasic ("saddleback") fever curve has been described in approximately 5 percent of cases; in such patients, acute febrile illness remits and then recurs approximately one to two days later; the second febrile phase lasts one to two days [<a href="#rid30">30</a>].</p><p>Leukopenia and thrombocytopenia (≤100,000 cells/mm<sup>3</sup>) are common [<a href="#rid29">29,30,37-40</a>]. Serum aspartate transaminase (AST) levels are frequently elevated; the elevations are usually modest (2 to 5 times the upper limit of normal values), but marked elevations (5 to 15 times the upper limit of normal) occasionally occur [<a href="#rid30">30,37</a>]. Elevated liver enzymes are common in the febrile phase; synthetic liver dysfunction (ie, elevated activated partial-thromboplastin time) and decreases in fibrinogen are not frequently identified.</p><p>Between days 3 and 7 of the illness, the clinician must watch for signs of vascular leakage. Significant vascular leakage reduces intravascular volume and decreases organ perfusion. Corresponding clinical manifestations may include persistent vomiting, increasingly severe abdominal pain, tender hepatomegaly, development of pleural effusions and/or ascites, mucosal bleeding, and lethargy or restlessness; laboratory findings may include a high or increasing hematocrit level (≥20 percent from baseline) concurrent with a rapid decrease in the platelet count [<a href="#rid32">32,33,41</a>]. (See <a class="local">'Dengue with warning signs'</a> above and <a class="local">'Critical phase'</a> below.)</p><p class="headingAnchor" id="H3232255688"><span class="h3">Critical phase</span><span class="headingEndMark"> — </span>The vast majority of infections that progress to a critical phase result from second DENV infections that occur more than 18 months after a resolved first infection. However, a subset of critical infections occur in children less than one year of age, at the time maternal antibody is below protective levels and the child experiences a primary wild type infection. In addition, severe DENV infection may occur after primary infection in individuals with significant medical comorbidities. </p><p>Around the time of defervescence (typically days 3 to 7 of infection), a small proportion of patients (typically children and young adults) develop a systemic vascular leak syndrome characterized by plasma leakage, bleeding, shock, and organ impairment [<a href="#rid37">37</a>]. The critical phase lasts for 24 to 48 hours.</p><p>Initially, adequate circulation may be maintained by physiologic compensation, resulting in pulse pressure narrowing (systolic pressure minus diastolic pressure ≤20 mmHg)  (<a class="graphic graphic_table graphicRef109848" href="/d/graphic/109848.html" rel="external">table 1</a>); the patient may appear well, and the systolic pressure may be normal or elevated. Nonetheless, urgent, careful resuscitation is needed; once hypotension develops, systolic pressure falls rapidly and irreversible shock may follow despite aggressive attempts at resuscitation [<a href="#rid4">4</a>]. (See <a class="local">'Dengue shock syndrome'</a> above and <a class="local">'Severe dengue'</a> above and  <a class="medical medical_review" href="/d/html/3030.html" rel="external">"Dengue virus infection: Prevention and treatment", section on 'Treatment approach'</a>.)</p><p>Hemorrhagic manifestations may be observed in the febrile phase and/or critical phase. (See <a class="local">'Febrile phase'</a> above.)</p><p>Imaging modalities for detection of plasma leakage include ultrasonography (of the chest and abdomen) and chest radiography. In one study including 158 patients with suspected DHF in Thailand, ultrasonography around the time of defervescence was helpful for detection of pleural effusion and peritoneal fluid; right lateral decubitus chest radiography was also useful for detection of pleural effusion [<a href="#rid42">42</a>]. Plasma leakage was detected by ultrasound as early as three days after onset of fever; pleural effusions were observed more commonly than ascites. Gallbladder wall thickening may also be evident [<a href="#rid43">43</a>].</p><p>Moderate-to-severe thrombocytopenia is common during the critical phase; nadir platelet counts ≤20,000 cells/mm<sup>3</sup> may be observed, followed by rapid improvement during the recovery phase [<a href="#rid1">1</a>]. A transient increase in the activated partial-thromboplastin time and decrease in fibrinogen levels are also common.</p><p>Reversion of the critical phase of altered vascular permeability corresponds with rapid improvement in symptoms.</p><p class="headingAnchor" id="H2840804725"><span class="h3">Recovery phase</span><span class="headingEndMark"> — </span>During the recovery phase, plasma leakage and hemorrhage resolve, vital signs stabilize, and accumulated fluids are resorbed. An additional rash (a confluent, erythematous eruption with small islands of unaffected skin that is often pruritic) may appear during the recovery phase (within one to two days of defervescence and lasting one to five days)  (<a class="graphic graphic_picture graphicRef97534" href="/d/graphic/97534.html" rel="external">picture 1</a>).</p><p>The recovery phase typically lasts two to four days; adults may have profound fatigue for days to weeks after recovery.</p><p class="headingAnchor" id="H1088431897"><span class="h2">Additional manifestations</span><span class="headingEndMark"> — </span>Additional manifestations of DENV infection (typically occurring in the critical phase or later) may include liver failure, central nervous system involvement, myocardial dysfunction, acute kidney injury, and others [<a href="#rid44">44-48</a>].</p><p>Liver failure has been described following resuscitation from profound shock; in many cases, it may be caused by prolonged hypoperfusion or hypoxia rather than a direct viral effect [<a href="#rid44">44,47</a>]. In addition, abdominal pain (occasionally mimicking an acute abdomen) has been described as a clinical manifestation in case series [<a href="#rid49">49,50</a>].</p><p>Neurologic manifestations associated with DENV infection include encephalopathy and seizures; permanent neurologic sequelae have been described [<a href="#rid44">44,45,51-53</a>]. In case series, the frequency of these manifestations is approximately 1 percent [<a href="#rid46">46</a>]. Clinical manifestations include fever, headache, and lethargy; some patients may have no characteristic features of DENV infection [<a href="#rid45">45</a>]. In such cases, the diagnosis has been supported by serologic testing, culture, or detection by polymerase chain reaction in cerebrospinal fluid [<a href="#rid45">45</a>]. Other neurologic syndromes that have been reported to be potentially associated with DENV infection include stroke, acute pure motor weakness, mononeuropathies, polyneuropathies, Guillain-Barré syndrome, and transverse myelitis [<a href="#rid45">45,46,48,54</a>].</p><p>Cardiovascular manifestations (including myocardial impairment, arrhythmias, and, occasionally, fulminant myocarditis) have been described in patients with DENV infection [<a href="#rid55">55-57</a>]. One study including 81 patients with DENV in Brazil noted elevated levels of troponin or B-type natriuretic peptide in 15 percent of cases [<a href="#rid56">56</a>]. Another study including 181 children with DENV infection noted transient left ventricular systolic and diastolic dysfunction was common and correlated with severity of plasma leakage [<a href="#rid58">58</a>]. Reports of histologic findings of myocarditis at autopsy have been notable for detection of DENV antigens in cardiomyocytes [<a href="#rid56">56,59</a>].</p><p>Acute kidney injury (AKI) has been reported in up to 3 percent of dengue cases [<a href="#rid60">60-63</a>]. Mechanisms of AKI may include shock, rhabdomyolysis, glomerulonephritis, and acute tubular necrosis [<a href="#rid64">64</a>].</p><p>Retinal vasculitis and hemophagocytic lymphohistiocytosis have been described in association with DENV infection [<a href="#rid65">65-67</a>].</p><p>Bacterial coinfection with or following DENV infection occurs but is rare. Risk factors include pre-existing comorbidities and severe illness at presentation. Persistent fever, rising white blood cell count, and signs and symptoms uncommon for dengue should prompt evaluation for bacterial coinfection [<a href="#rid68">68,69</a>].</p><p>Secondary hemophagocytic lymphohistiocytosis is a potentially fatal hyperinflammatory condition and has been recognized in cases of severe dengue [<a href="#rid70">70,71</a>]. </p><p class="headingAnchor" id="H3525573515"><span class="h2">Immunized individuals</span><span class="headingEndMark"> — </span>Dengue vaccines may not provide complete protection from dengue disease; immunized individuals may present with attenuated disease. In addition, there is a theoretical possibility that immunization with a poorly immunogenic dengue vaccine could increase the risk of severe dengue infection with subsequent exposure to wild-type virus. Issues related to dengue vaccination are discussed separately. (See  <a class="medical medical_review" href="/d/html/3030.html" rel="external">"Dengue virus infection: Prevention and treatment"</a>.)</p><p class="headingAnchor" id="H18"><span class="h1">DIAGNOSIS</span></p><p class="headingAnchor" id="H244002665"><span class="h2">Clinical approach</span><span class="headingEndMark"> — </span>The diagnosis of DENV infection should be suspected in febrile individuals with typical clinical manifestations (fever, headache, nausea, vomiting, retro-orbital pain, myalgia, arthralgia, rash, hemorrhagic manifestations, positive tourniquet test, leukopenia) and relevant epidemiologic exposure (residence in or travel within the past two weeks to an area with mosquito-borne transmission of DENV infection). (See  <a class="medical medical_review" href="/d/html/3028.html" rel="external">"Dengue virus infection: Epidemiology"</a>.)</p><p>A provisional diagnosis of DENV infection is usually established clinically. In regions and seasons with a high incidence of DENV infection, the positive predictive value of clinical criteria is high, particularly for illnesses meeting all criteria for dengue hemorrhagic fever (DHF) [<a href="#rid72">72</a>]. (See <a class="local">'Dengue hemorrhagic fever'</a> above.)</p><p>Early clinical presentations of dengue, chikungunya, and Zika virus infection may be indistinguishable. If feasible, laboratory diagnostic confirmation is warranted, but often the results are not available soon enough to guide initial clinical management.</p><p class="headingAnchor" id="H20"><span class="h2">Laboratory testing</span><span class="headingEndMark"> — </span>Laboratory diagnosis of DENV infection is established directly by detection of viral components in serum or indirectly by serology. The sensitivity of each approach depends on the duration of the patient's illness as well as when in the course of illness the patient presents for evaluation  (<a class="graphic graphic_figure graphicRef113221" href="/d/graphic/113221.html" rel="external">figure 1</a>). Detection of viral nucleic acid or viral antigen has high specificity but is more labor intensive and costly; serology has lower specificity but is more accessible and less costly.</p><p>During the first week of illness, the diagnosis of DENV infection may be established via detection of viral nucleic acid in serum by means of reverse-transcriptase polymerase chain reaction assay (typically positive during the first five days of illness) <strong>or</strong> via detection of viral antigen nonstructural protein 1 (NS1; typically positive during the first seven days of illness). In primary infection, the sensitivity of NS1 detection can exceed 90 percent, and antigenemia may persist for several days after resolution of fever; in secondary infection, the sensitivity of NS1 detection is lower (60 to 80 percent) [<a href="#rid73">73-75</a>].</p><p>Immunoglobulin (Ig)M can be detected as early as four days after the onset of illness by lateral flow immunoassay or IgM antibody capture enzyme-linked immunosorbent assay  (<a class="graphic graphic_figure graphicRef113222" data-inline-graphics="113222" href="/d/graphic/113222.html" rel="external">figure 2</a>) [<a href="#rid1">1</a>]. Detection of IgM in a single specimen obtained from a patient with a clinical syndrome consistent with dengue is widely used to establish a presumptive diagnosis. The diagnosis may be confirmed via IgM seroconversion between paired acute and recovery phase (obtained 10 to 14 days after the acute phase) specimens; a diagnosis of acute DENV infection may be established by a fourfold or greater rise in antibody titer. </p><p>For symptomatic patients with epidemiologic risk for infection with Zika virus as well as the DENVs, the diagnostic approach is summarized in the figure  (<a class="graphic graphic_algorithm graphicRef121614" data-inline-graphics="121614" href="/d/graphic/121614.html" rel="external">algorithm 1</a> and <a class="graphic graphic_table graphicRef121613" href="/d/graphic/121613.html" rel="external">table 2</a>) [<a href="#rid76">76</a>]. (See  <a class="medical medical_review" href="/d/html/106169.html" rel="external">"Zika virus infection: An overview", section on 'Epidemiology'</a>.)</p><p>The likelihood of IgG detection depends on whether the infection is primary or secondary  (<a class="graphic graphic_figure graphicRef113222" href="/d/graphic/113222.html" rel="external">figure 2</a>). Primary DENV infection is characterized by a slow and low titer antibody response; IgG is detectable at low titer beginning seven days after onset of illness and increases slowly. Secondary DENV infection is characterized by a rapid rise in antibody titer beginning four days after onset of illness, with broad cross-reactivity.</p><p>Serologic tests are unreliable for diagnosis of acute DENV infection in individuals who have been vaccinated with a dengue vaccine within the previous several months [<a href="#rid77">77</a>]. In addition, serologic diagnosis of dengue may be confounded in the setting of recent infection or vaccination with an antigenically related flavivirus such as yellow fever virus, Japanese encephalitis virus, or Zika virus. (See  <a class="medical medical_review" href="/d/html/3030.html" rel="external">"Dengue virus infection: Prevention and treatment"</a>.)</p><p>DENV infection can be established by virus isolation (culture); in general, this is not warranted as a clinical diagnostic tool since results are usually not available in a clinically meaningful time frame.</p><p>Dengue viral proteins can be detected in tissue samples using immunohistochemical staining [<a href="#rid78">78</a>]. Liver tissues appear to have the high yield; biopsy is rarely indicated in patients with suspected DENV infection, so this method is generally used only for postmortem diagnosis.</p><p class="headingAnchor" id="H4157314730"><span class="h1">DIFFERENTIAL DIAGNOSIS</span><span class="headingEndMark"> — </span>The differential diagnosis of DENV infection includes:</p><p class="bulletIndent1"><span class="glyph">●</span>Other viral hemorrhagic fevers – Other viruses capable of causing hemorrhagic fever include Ebola virus, Marburg virus, Lassa virus, yellow fever virus, Crimean-Congo hemorrhagic fever, hantavirus (hemorrhagic fever with renal syndrome), and severe fever with thrombocytopenia syndrome virus (SFTSV). These illnesses can all cause severe multiorgan system illness accompanied by hemorrhage. The diseases may be distinguished based on relevant epidemiologic exposure and polymerase chain reaction or serologic testing. (See  <a class="medical medical_review" href="/d/html/3022.html" rel="external">"Clinical manifestations and diagnosis of Ebola virus disease"</a> and  <a class="medical medical_review" href="/d/html/98084.html" rel="external">"Marburg virus"</a> and  <a class="medical medical_review" href="/d/html/3032.html" rel="external">"Yellow fever: Epidemiology, clinical manifestations, and diagnosis"</a> and  <a class="medical medical_review" href="/d/html/103771.html" rel="external">"Lassa fever"</a> and  <a class="medical medical_review" href="/d/html/102363.html" rel="external">"Crimean-Congo hemorrhagic fever"</a> and  <a class="medical medical_review" href="/d/html/7240.html" rel="external">"Kidney involvement in hantavirus infections"</a> and  <a class="medical medical_review" href="/d/html/88736.html" rel="external">"Severe fever with thrombocytopenia syndrome virus"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Chikungunya – Chikungunya virus and DENV cause similar symptoms and signs and are transmitted by the same mosquito vector  (<a class="graphic graphic_table graphicRef106512" data-inline-graphics="106512" href="/d/graphic/106512.html" rel="external">table 3</a>). In studies comparing the two diseases, joint pain was reported somewhat more often by patients with chikungunya, whereas abdominal pain and leukopenia were more common in those with dengue [<a href="#rid79">79-81</a>]. Joint swelling is highly specific for chikungunya; bleeding manifestations and thrombocytopenia are relatively specific for dengue. The diagnosis of chikungunya virus infection is established via serology or reverse-transcriptase polymerase chain reaction (RT-PCR). (See  <a class="medical medical_review" href="/d/html/3024.html" rel="external">"Chikungunya fever: Epidemiology, clinical manifestations, and diagnosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Zika virus infection – DENV and Zika virus infections have similar clinical manifestations and are transmitted by the same mosquito vector. Unlike DENV infection, Zika is commonly associated with conjunctivitis  (<a class="graphic graphic_table graphicRef106512" href="/d/graphic/106512.html" rel="external">table 3</a>). Coinfection with Zika, chikungunya, and DENVs has been described [<a href="#rid82">82-84</a>]. The diagnosis of Zika virus infection is established via serology or RT-PCR  (<a class="graphic graphic_algorithm graphicRef121614" href="/d/graphic/121614.html" rel="external">algorithm 1</a> and <a class="graphic graphic_table graphicRef121613" href="/d/graphic/121613.html" rel="external">table 2</a>) [<a href="#rid76">76</a>]. (See  <a class="medical medical_review" href="/d/html/106169.html" rel="external">"Zika virus infection: An overview"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Malaria – Malaria is characterized by fever, malaise, nausea, vomiting, abdominal pain, diarrhea, myalgia, and anemia. The diagnosis of malaria is established by rapid antigen test or by visualization of parasites on peripheral smear. (See  <a class="medical medical_review" href="/d/html/5709.html" rel="external">"Malaria: Clinical manifestations and diagnosis in nonpregnant adults and children"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Typhoid fever – Clinical manifestations of typhoid fever include fever, bradycardia, abdominal pain, and rash. The diagnosis is established by stool and/or blood culture. (See  <a class="medical medical_review" href="/d/html/2708.html" rel="external">"Enteric (typhoid and paratyphoid) fever: Epidemiology, clinical manifestations, and diagnosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Leptospirosis – Leptospirosis is characterized by fever, rigors, myalgia, conjunctival suffusion, and headache. Less common symptoms and signs include cough, nausea, vomiting, diarrhea, abdominal pain, and arthralgia. The diagnosis is established via serology. (See  <a class="medical medical_review" href="/d/html/5527.html" rel="external">"Leptospirosis: Epidemiology, microbiology, clinical manifestations, and diagnosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Parvovirus B19 – In children, parvovirus presents most commonly as a mild febrile illness characterized by an erythematous malar rash followed by a lacy rash over the trunk and extremities. In adults, parvovirus may present as an acute arthritis involving the small joints of the hands, wrists, knees, and feet, with or without a rash. The diagnosis may be established via serology or nucleic acid testing [<a href="#rid85">85</a>]. (See  <a class="medical medical_review" href="/d/html/8272.html" rel="external">"Clinical manifestations and diagnosis of parvovirus B19 infection"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Acute HIV infection – A variety of symptoms and signs may occur in association with acute HIV infection; the most common findings are fever, lymphadenopathy, sore throat, rash, myalgia/arthralgia, and headache. Other manifestations include painful mucocutaneous ulceration and aseptic meningitis. Diagnostic testing consists of an HIV immunoassay (ideally, a combination antigen/antibody immunoassay) and an HIV virologic (viral load) test. (See  <a class="medical medical_review" href="/d/html/86984.html" rel="external">"Acute and early HIV infection: Clinical manifestations and diagnosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Viral hepatitis – Causes of viral hepatitis include hepatitis A, B, C, D, and E. Hepatitis A and E are acute infections transmitted by the fecal-oral route, whereas hepatitis B, C, and D can present acutely or chronically and are transmitted by body fluids. They are distinguished via serology and PCR (see related topics).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Rickettsial infection – Rickettsial infections with similar manifestations as DENV infection include African tick bite fever and relapsing fever. African tick bite fever is observed among travelers to Africa and the Caribbean and is characterized by headache, fever, myalgia, solitary or multiple eschars with regional lymphadenopathy, and generalized rash; the diagnosis is established via serology. Relapsing fever is characterized by fever, headache, neck stiffness, arthralgia, myalgia, and nausea; diagnostic tools include direct smear and polymerase chain reaction. (See  <a class="medical medical_review" href="/d/html/7908.html" rel="external">"Other spotted fever group rickettsial infections"</a> and  <a class="medical medical_review" href="/d/html/7897.html" rel="external">"Clinical features, diagnosis, and management of relapsing fever"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Sepsis due to bacteremia – Sepsis due to bacteremia may present with fever, tachycardia, and altered mental status; diagnosis requires blood culture.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Influenza – Symptoms of influenza virus infection include abrupt onset of fever, headache, myalgia, and malaise, accompanied by manifestations of respiratory-tract illness, such as cough, sore throat, and rhinitis. The diagnosis is established via molecular testing of a nasopharyngeal specimen; other diagnostic tools are also available. (See  <a class="medical medical_review" href="/d/html/7004.html" rel="external">"Seasonal influenza in adults: Clinical manifestations and diagnosis"</a> and  <a class="medical medical_review" href="/d/html/5973.html" rel="external">"Seasonal influenza in children: Clinical features and diagnosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Coronavirus disease 2019 (COVID-19) – Symptoms of COVID-19 include fever, cough, and/or dyspnea; other features, including upper respiratory tract symptoms, myalgias, diarrhea, and loss of senses of smell or taste are also common. Laboratory manifestations may include lymphopenia and elevated liver enzymes. The diagnosis is established via molecular testing of a nasopharyngeal specimen; other diagnostic tools are also available. (See  <a class="medical medical_review" href="/d/html/128323.html" rel="external">"COVID-19: Clinical features"</a> and  <a class="medical medical_review" href="/d/html/128404.html" rel="external">"COVID-19: Diagnosis"</a>.) </p><p></p><p class="headingAnchor" id="H2273977994"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/118425.html" rel="external">"Society guideline links: Dengue virus"</a>.)</p><p class="headingAnchor" id="H99088459"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)</p><p class="bulletIndent1"><span class="glyph">●</span>Basics topic (see  <a class="medical medical_basics" href="/d/html/83159.html" rel="external">"Patient education: Dengue fever (The Basics)"</a>)</p><p></p><p class="headingAnchor" id="H24"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical manifestations</strong> – The three clinical phases of dengue are febrile phase, critical phase, and recovery phase. The critical phase is not seen in all infections. (See <a class="local">'Phases of infection'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Febrile phase</strong> – The febrile phase usually lasts three to seven days. (See <a class="local">'Febrile phase'</a> above.)</p><p></p><p class="bulletIndent3"><span class="glyph">-</span><strong>Symptoms</strong> – Fever is nearly universal and is typically ≥38.5°C. Other common, acute symptoms include headache, retro-orbital pain, and marked myalgia and arthralgia. A transient macular rash may develop two to five days after onset of fever  (<a class="graphic graphic_picture graphicRef97534" href="/d/graphic/97534.html" rel="external">picture 1</a> and <a class="graphic graphic_picture graphicRef97996" href="/d/graphic/97996.html" rel="external">picture 2</a>).</p><p></p><p class="bulletIndent3"><span class="glyph">-</span><strong>Physical examination</strong> – Findings may include rash, conjunctival injection, pharyngeal erythema, and hemorrhagic features (eg, petechiae, ecchymoses, vaginal or gastrointestinal bleeding). A tourniquet test (performed by inflating a blood pressure cuff on the arm to midway between systolic and diastolic blood pressures for five minutes) usually reveals petechiae one to two minutes after deflating the cuff  (<a class="graphic graphic_picture graphicRef97567" href="/d/graphic/97567.html" rel="external">picture 3</a>).</p><p></p><p class="bulletIndent3"><span class="glyph">-</span><strong>Laboratory findings</strong> – Typical findings include leukopenia, thrombocytopenia, and elevated aminotransferases.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Critical phase</strong> – At defervescence, a small proportion of patients (usually children and young adults) develop plasma leakage, bleeding, shock, and organ impairment or failure, which usually lasts 24 to 48 hours. The extent of plasma leakage varies, and mild plasma leakage is not always associated with shock or organ failure. (See <a class="local">'Critical phase'</a> above.)</p><p></p><p class="bulletIndent3"><span class="glyph">-</span><strong>Warning signs</strong> – Signs of impending critical illness include persistent vomiting, severe abdominal pain, tender hepatomegaly, pleural effusion, ascites, mucosal bleeding, and lethargy or restlessness. Physical examination may reveal narrowed pulse pressure followed by hypotension and shock. Laboratory findings may include a high or increasing hematocrit (≥20 percent from baseline), a rapid decrease in platelets, increased activated partial-thromboplastin time, and decreased fibrinogen levels. (See <a class="local">'Dengue with warning signs'</a> above.)</p><p></p><p class="bulletIndent2">The vast majority of infections that progress to a critical phase result from a second DENV infection with a different DENV type than the first infection and occurs more than 18 months after a first infection. (See <a class="local">'Critical phase'</a> above and  <a class="medical medical_review" href="/d/html/3029.html" rel="external">"Dengue virus infection: Pathogenesis", section on 'Prior dengue exposure'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Recovery phase</strong> – During the recovery phase, plasma leakage and hemorrhage resolve, vital signs stabilize, and accumulated fluids are resorbed. A pruritic confluent, erythematous eruption with small islands of unaffected skin may appear  (<a class="graphic graphic_picture graphicRef97534" href="/d/graphic/97534.html" rel="external">picture 1</a>). The recovery phase typically lasts two to four days, but adults may have profound fatigue for days to weeks after recovery.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Diagnosis</strong> – Diagnosis is often made clinically although laboratory diagnostic testing allows confirmation of disease.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Clinical diagnosis</strong> – A provisional diagnosis is based on typical clinical manifestations (fever, headache, nausea, vomiting, retro-orbital pain, myalgia, arthralgia, rash, hemorrhagic manifestations, positive tourniquet test, leukopenia) coupled with exposure to a dengue-endemic country or region. (See <a class="local">'Clinical approach'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Confirmatory diagnostic tests</strong> (see <a class="local">'Laboratory testing'</a> above) – </p><p></p><p class="bulletIndent3"><span class="glyph">-</span><strong>Detection of viral protein or genome</strong> – Polymerase chain reaction (PCR) to detect viral genomes and antigen tests are typically positive during the first week of illness.</p><p></p><p class="bulletIndent3"><span class="glyph">-</span><strong>Serology </strong> (<a class="graphic graphic_figure graphicRef113222" href="/d/graphic/113222.html" rel="external">figure 2</a>) – Virus-specific IgM positivity develops around the fourth day of illness and is widely used to make a presumptive diagnosis. The diagnosis may be confirmed via IgM seroconversion between paired acute and recovery phase (obtained 10 to 14 days after the acute phase) specimens; a diagnosis of acute DENV infection may be established by a significant rise in antibody levels as specified by the test). </p><p></p><p class="bulletIndent3">Virus-specific IgG positivity generally develops slowly but may occur as early as seven days after onset of illness. Baseline IgG positivity may be present in individuals with prior Dengue virus infection or vaccination.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Differential diagnosis</strong> – Alternative diagnoses include other viral hemorrhagic fevers, some of which require strict infection control measures. Other infections to be considered include Chikungunya or Zika virus  (<a class="graphic graphic_table graphicRef106512" href="/d/graphic/106512.html" rel="external">table 3</a>), malaria, typhoid fever, leptospirosis, acute HIV infection, rickettsial infection, and sepsis due to bacteremia. (See <a class="local">'Differential diagnosis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Immunized individuals</strong> – Immunized individuals may present with attenuated disease. Those without prior Dengue infection may be at increased risk of severe disease if natural infection occurs following vaccination. Issues related to dengue vaccine are discussed separately. (See  <a class="medical medical_review" href="/d/html/3030.html" rel="external">"Dengue virus infection: Prevention and treatment"</a>.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Simmons CP, Farrar JJ, Nguyen vV, Wills B. Dengue. N Engl J Med 2012; 366:1423.</a></li><li><a class="nounderline abstract_t">Guzman MG, Harris E. Dengue. Lancet 2015; 385:453.</a></li><li><a class="nounderline abstract_t">Kularatne SA. Dengue fever. BMJ 2015; 351:h4661.</a></li><li class="breakAll">World Health Organization. Dengue haemorrhagic fever: Diagnosis, treatment, prevention and control, 2nd edition. WHO, Geneva 1997. http://apps.who.int/iris/bitstream/10665/41988/1/9241545003_eng.pdf (Accessed on December 07, 2016).</li><li><a class="nounderline abstract_t">Phuong CX, Nhan NT, Kneen R, et al. Clinical diagnosis and assessment of severity of confirmed dengue infections in Vietnamese children: is the world health organization classification system helpful? Am J Trop Med Hyg 2004; 70:172.</a></li><li><a class="nounderline abstract_t">Wichmann O, Gascon J, Schunk M, et al. Severe dengue virus infection in travelers: risk factors and laboratory indicators. J Infect Dis 2007; 195:1089.</a></li><li><a class="nounderline abstract_t">Srikiatkhachorn A, Gibbons RV, Green S, et al. Dengue hemorrhagic fever: the sensitivity and specificity of the world health organization definition for identification of severe cases of dengue in Thailand, 1994-2005. Clin Infect Dis 2010; 50:1135.</a></li><li><a class="nounderline abstract_t">Anderson KB, Chunsuttiwat S, Nisalak A, et al. Burden of symptomatic dengue infection in children at primary school in Thailand: a prospective study. Lancet 2007; 369:1452.</a></li><li class="breakAll">World Health Organization. Dengue: Guidelines for diagnosis, treatment, prevention and control, New edition. WHO: Geneva 2009. http://www.who.int/tdr/publications/documents/dengue-diagnosis.pdf?ua=1 (Accessed on December 07, 2016).</li><li><a class="nounderline abstract_t">Srikiatkhachorn A, Rothman AL, Gibbons RV, et al. Dengue--how best to classify it. Clin Infect Dis 2011; 53:563.</a></li><li class="breakAll">Comprehensive Guideline for Prevention and Control of Dengue and Dengue Haemorrhagic Fever. Revised and expanded edition. World Health Organization. Available at: https://apps.who.int/iris/handle/10665/204894. (Accessed on July 19, 2022).</li><li><a class="nounderline abstract_t">Zakaria Z, Zainordin NA, Sim BL, et al. An evaluation of the World Health Organization's 1997 and 2009 dengue classifications in hospitalized dengue patients in Malaysia. J Infect Dev Ctries 2014; 8:869.</a></li><li><a class="nounderline abstract_t">Horstick O, Jaenisch T, Martinez E, et al. Comparing the usefulness of the 1997 and 2009 WHO dengue case classification: a systematic literature review. Am J Trop Med Hyg 2014; 91:621.</a></li><li><a class="nounderline abstract_t">Nujum ZT, Thomas A, Vijayakumar K, et al. Comparative performance of the probable case definitions of dengue by WHO (2009) and the WHO-SEAR expert group (2011). Pathog Glob Health 2014; 108:103.</a></li><li><a class="nounderline abstract_t">Gan VC, Lye DC, Thein TL, et al. Implications of discordance in world health organization 1997 and 2009 dengue classifications in adult dengue. PLoS One 2013; 8:e60946.</a></li><li><a class="nounderline abstract_t">Wieten RW, Vlietstra W, Goorhuis A, et al. Dengue in travellers: applicability of the 1975-1997 and the 2009 WHO classification system of dengue fever. Trop Med Int Health 2012; 17:1023.</a></li><li class="breakAll">World Health Organization Regional Office for Southeast Asia. Comprehensive guidelines for prevention and control of dengue and dengue haemorrhagic fever. Revised and expanded version. SEARO Technical Publication Series, New Delhi, India 2011.</li><li class="breakAll">World Health Organization. Handbook for clinical management of dengue. WHO, Geneva 2012. https://apps.who.int/iris/bitstream/handle/10665/76887/9789241504713_eng.pdf?sequence=1&amp;isAllowed=y (Accessed on September 13, 2016).</li><li><a class="nounderline abstract_t">Rigau-Pérez JG, Laufer MK. Dengue-related deaths in Puerto Rico, 1992-1996: diagnosis and clinical alarm signals. Clin Infect Dis 2006; 42:1241.</a></li><li><a class="nounderline abstract_t">Deen JL, Harris E, Wills B, et al. The WHO dengue classification and case definitions: time for a reassessment. Lancet 2006; 368:170.</a></li><li><a class="nounderline abstract_t">Bhatt S, Gething PW, Brady OJ, et al. The global distribution and burden of dengue. Nature 2013; 496:504.</a></li><li><a class="nounderline abstract_t">SABIN AB. Research on dengue during World War II. Am J Trop Med Hyg 1952; 1:30.</a></li><li><a class="nounderline abstract_t">Endy TP, Chunsuttiwat S, Nisalak A, et al. Epidemiology of inapparent and symptomatic acute dengue virus infection: a prospective study of primary school children in Kamphaeng Phet, Thailand. Am J Epidemiol 2002; 156:40.</a></li><li><a class="nounderline abstract_t">Cobra C, Rigau-Pérez JG, Kuno G, Vorndam V. Symptoms of dengue fever in relation to host immunologic response and virus serotype, Puerto Rico, 1990-1991. Am J Epidemiol 1995; 142:1204.</a></li><li><a class="nounderline abstract_t">L'Azou M, Moureau A, Sarti E, et al. Symptomatic Dengue in Children in 10 Asian and Latin American Countries. N Engl J Med 2016; 374:1155.</a></li><li><a class="nounderline abstract_t">Anderson KB, Gibbons RV, Cummings DA, et al. A shorter time interval between first and second dengue infections is associated with protection from clinical illness in a school-based cohort in Thailand. J Infect Dis 2014; 209:360.</a></li><li><a class="nounderline abstract_t">Montoya M, Gresh L, Mercado JC, et al. Symptomatic versus inapparent outcome in repeat dengue virus infections is influenced by the time interval between infections and study year. PLoS Negl Trop Dis 2013; 7:e2357.</a></li><li><a class="nounderline abstract_t">Fukusumi M, Arashiro T, Arima Y, et al. Dengue Sentinel Traveler Surveillance: Monthly and Yearly Notification Trends among Japanese Travelers, 2006-2014. PLoS Negl Trop Dis 2016; 10:e0004924.</a></li><li><a class="nounderline abstract_t">Trofa AF, DeFraites RF, Smoak BL, et al. Dengue fever in US military personnel in Haiti. JAMA 1997; 277:1546.</a></li><li><a class="nounderline abstract_t">Leder K, Torresi J, Brownstein JS, et al. Travel-associated illness trends and clusters, 2000-2010. Emerg Infect Dis 2013; 19:1049.</a></li><li><a class="nounderline abstract_t">Cao XT, Ngo TN, Wills B, et al. Evaluation of the World Health Organization standard tourniquet test and a modified tourniquet test in the diagnosis of dengue infection in Viet Nam. Trop Med Int Health 2002; 7:125.</a></li><li><a class="nounderline abstract_t">Díaz A, Kourí G, Guzmán MG, et al. Description of the clinical picture of dengue hemorrhagic fever/dengue shock syndrome (DHF/DSS) in adults. Bull Pan Am Health Organ 1988; 22:133.</a></li><li><a class="nounderline abstract_t">Guzmán MG, Kourí G, Martínez E, et al. Clinical and serologic study of Cuban children with dengue hemorrhagic fever/dengue shock syndrome (DHF/DSS). Bull Pan Am Health Organ 1987; 21:270.</a></li><li><a class="nounderline abstract_t">Chhong LN, Poovorawan K, Hanboonkunupakarn B, et al. Prevalence and clinical manifestations of dengue in older patients in Bangkok Hospital for Tropical Diseases, Thailand. Trans R Soc Trop Med Hyg 2020; 114:674.</a></li><li><a class="nounderline abstract_t">Cunha BA, Apostolopoulou A, Sivarajah T, Klein NC. Facial Puffiness in a Returning Traveler From Puerto Rico: Chikungunya, Dengue Fever, or Zika Virus? Clin Infect Dis 2016; 63:1264.</a></li><li><a class="nounderline abstract_t">Wilder-Smith A, Schwartz E. Dengue in travelers. N Engl J Med 2005; 353:924.</a></li><li><a class="nounderline abstract_t">Kalayanarooj S, Vaughn DW, Nimmannitya S, et al. Early clinical and laboratory indicators of acute dengue illness. J Infect Dis 1997; 176:313.</a></li><li><a class="nounderline abstract_t">Potts JA, Rothman AL. Clinical and laboratory features that distinguish dengue from other febrile illnesses in endemic populations. Trop Med Int Health 2008; 13:1328.</a></li><li><a class="nounderline abstract_t">Halstead SB. Dengue. Lancet 2007; 370:1644.</a></li><li><a class="nounderline abstract_t">Tanner L, Schreiber M, Low JG, et al. Decision tree algorithms predict the diagnosis and outcome of dengue fever in the early phase of illness. PLoS Negl Trop Dis 2008; 2:e196.</a></li><li><a class="nounderline abstract_t">Khor BS, Liu JW, Lee IK, Yang KD. Dengue hemorrhagic fever patients with acute abdomen: clinical experience of 14 cases. Am J Trop Med Hyg 2006; 74:901.</a></li><li><a class="nounderline abstract_t">Srikiatkhachorn A, Krautrachue A, Ratanaprakarn W, et al. Natural history of plasma leakage in dengue hemorrhagic fever: a serial ultrasonographic study. Pediatr Infect Dis J 2007; 26:283.</a></li><li><a class="nounderline abstract_t">Ferreira BDC, Correia D. Ultrasound Assessment of Hepatobiliary and Splenic Changes in Patients With Dengue and Warning Signs During the Acute and Recovery Phases. J Ultrasound Med 2019; 38:2015.</a></li><li><a class="nounderline abstract_t">Chhour YM, Ruble G, Hong R, et al. Hospital-based diagnosis of hemorrhagic fever, encephalitis, and hepatitis in Cambodian children. Emerg Infect Dis 2002; 8:485.</a></li><li><a class="nounderline abstract_t">Solomon T, Dung NM, Vaughn DW, et al. Neurological manifestations of dengue infection. Lancet 2000; 355:1053.</a></li><li><a class="nounderline abstract_t">Carod-Artal FJ, Wichmann O, Farrar J, Gascón J. Neurological complications of dengue virus infection. Lancet Neurol 2013; 12:906.</a></li><li><a class="nounderline abstract_t">Neeraja M, Iakshmi V, Teja VD, et al. Unusual and rare manifestations of dengue during a dengue outbreak in a tertiary care hospital in South India. Arch Virol 2014; 159:1567.</a></li><li><a class="nounderline abstract_t">Verma R, Sahu R, Holla V. Neurological manifestations of dengue infection: a review. J Neurol Sci 2014; 346:26.</a></li><li><a class="nounderline abstract_t">Pires Neto Rda J, de Sá SL, Pinho SC, et al. Dengue infection in children and adolescents: clinical profile in a reference hospital in northeast Brazil. Rev Soc Bras Med Trop 2013; 46:765.</a></li><li><a class="nounderline abstract_t">Chia PY, Thein TL, Ong SWX, et al. Severe dengue and liver involvement: an overview and review of the literature. Expert Rev Anti Infect Ther 2020; 18:181.</a></li><li><a class="nounderline abstract_t">Misra UK, Kalita J, Syam UK, Dhole TN. Neurological manifestations of dengue virus infection. J Neurol Sci 2006; 244:117.</a></li><li><a class="nounderline abstract_t">Araújo FM, Araújo MS, Nogueira RM, et al. Central nervous system involvement in dengue: a study in fatal cases from a dengue endemic area. Neurology 2012; 78:736.</a></li><li><a class="nounderline abstract_t">Sahu R, Verma R, Jain A, et al. Neurologic complications in dengue virus infection: a prospective cohort study. Neurology 2014; 83:1601.</a></li><li><a class="nounderline abstract_t">Li HM, Huang YK, Su YC, Kao CH. Risk of stroke in patients with dengue fever: a population-based cohort study. CMAJ 2018; 190:E285.</a></li><li><a class="nounderline abstract_t">Yacoub S, Griffiths A, Chau TT, et al. Cardiac function in Vietnamese patients with different dengue severity grades. Crit Care Med 2012; 40:477.</a></li><li><a class="nounderline abstract_t">Miranda CH, Borges Mde C, Matsuno AK, et al. Evaluation of cardiac involvement during dengue viral infection. Clin Infect Dis 2013; 57:812.</a></li><li><a class="nounderline abstract_t">Yacoub S, Wertheim H, Simmons CP, et al. Cardiovascular manifestations of the emerging dengue pandemic. Nat Rev Cardiol 2014; 11:335.</a></li><li><a class="nounderline abstract_t">Kirawittaya T, Yoon IK, Wichit S, et al. Evaluation of Cardiac Involvement in Children with Dengue by Serial Echocardiographic Studies. PLoS Negl Trop Dis 2015; 9:e0003943.</a></li><li><a class="nounderline abstract_t">Salgado DM, Eltit JM, Mansfield K, et al. Heart and skeletal muscle are targets of dengue virus infection. Pediatr Infect Dis J 2010; 29:238.</a></li><li><a class="nounderline abstract_t">Lee IK, Liu JW, Yang KD. Clinical characteristics, risk factors, and outcomes in adults experiencing dengue hemorrhagic fever complicated with acute renal failure. Am J Trop Med Hyg 2009; 80:651.</a></li><li><a class="nounderline abstract_t">Laoprasopwattana K, Pruekprasert P, Dissaneewate P, et al. Outcome of dengue hemorrhagic fever-caused acute kidney injury in Thai children. J Pediatr 2010; 157:303.</a></li><li><a class="nounderline abstract_t">Basu G, Chrispal A, Boorugu H, et al. Acute kidney injury in tropical acute febrile illness in a tertiary care centre--RIFLE criteria validation. Nephrol Dial Transplant 2011; 26:524.</a></li><li><a class="nounderline abstract_t">Huang SY, Lee IK, Liu JW, et al. Clinical features of and risk factors for rhabdomyolysis among adult patients with dengue virus infection. Am J Trop Med Hyg 2015; 92:75.</a></li><li><a class="nounderline abstract_t">Shastri PS, Gupta P, Kumar R. A prospective 3 year study of clinical spectrum and outcome of dengue fever in ICU from a tertiary care hospital in North India. Indian J Anaesth 2020; 64:181.</a></li><li><a class="nounderline abstract_t">Chan DP, Teoh SC, Tan CS, et al. Ophthalmic complications of dengue. Emerg Infect Dis 2006; 12:285.</a></li><li><a class="nounderline abstract_t">Tan LH, Lum LC, Omar SF, Kan FK. Hemophagocytosis in dengue: comprehensive report of six cases. J Clin Virol 2012; 55:79.</a></li><li><a class="nounderline abstract_t">Sharp TM, Gaul L, Muehlenbachs A, et al. Fatal hemophagocytic lymphohistiocytosis associated with locally acquired dengue virus infection - New Mexico and Texas, 2012. MMWR Morb Mortal Wkly Rep 2014; 63:49.</a></li><li><a class="nounderline abstract_t">Thein TL, Ng EL, Yeang MS, et al. Risk factors for concurrent bacteremia in adult patients with dengue. J Microbiol Immunol Infect 2017; 50:314.</a></li><li><a class="nounderline abstract_t">Trunfio M, Savoldi A, Viganò O, d'Arminio Monforte A. Bacterial coinfections in dengue virus disease: what we know and what is still obscure about an emerging concern. Infection 2017; 45:1.</a></li><li><a class="nounderline abstract_t">Kan FK, Tan CC, Von Bahr Greenwood T, et al. Dengue Infection Complicated by Hemophagocytic Lymphohistiocytosis: Experiences From 180 Patients With Severe Dengue. Clin Infect Dis 2020; 70:2247.</a></li><li><a class="nounderline abstract_t">Bhattacharya D, Angurana SK, Nallasamy K, et al. Severe Dengue and Associated Hemophagocytic Lymphohistiocytosis in PICU. Indian J Pediatr 2019; 86:1094.</a></li><li><a class="nounderline abstract_t">Kalayanarooj S, Chansiriwongs V, Nimmannitya S. Dengue patients at the Children’s Hospital, Bangkok: 1995-1999 review. Dengue Bulletin 2002; 26:33.</a></li><li><a class="nounderline abstract_t">Guzman MG, Jaenisch T, Gaczkowski R, et al. Multi-country evaluation of the sensitivity and specificity of two commercially-available NS1 ELISA assays for dengue diagnosis. PLoS Negl Trop Dis 2010; 4.</a></li><li><a class="nounderline abstract_t">Hunsperger EA, Muñoz-Jordán J, Beltran M, et al. Performance of Dengue Diagnostic Tests in a Single-Specimen Diagnostic Algorithm. J Infect Dis 2016; 214:836.</a></li><li><a class="nounderline abstract_t">Huits R, Soentjens P, Maniewski-Kelner U, et al. Clinical Utility of the Nonstructural 1 Antigen Rapid Diagnostic Test in the Management of Dengue in Returning Travelers With Fever. Open Forum Infect Dis 2017; 4:ofw273.</a></li><li><a class="nounderline abstract_t">Sharp TM, Fischer M, Muñoz-Jordán JL, et al. Dengue and Zika Virus Diagnostic Testing for Patients with a Clinically Compatible Illness and Risk for Infection with Both Viruses. MMWR Recomm Rep 2019; 68:1.</a></li><li><a class="nounderline abstract_t">Plennevaux E, Moureau A, Arredondo-García JL, et al. Impact of Dengue Vaccination on Serological Diagnosis: Insights From Phase III Dengue Vaccine Efficacy Trials. Clin Infect Dis 2018; 66:1164.</a></li><li><a class="nounderline abstract_t">Jessie K, Fong MY, Devi S, et al. Localization of dengue virus in naturally infected human tissues, by immunohistochemistry and in situ hybridization. J Infect Dis 2004; 189:1411.</a></li><li><a class="nounderline abstract_t">Taraphdar D, Sarkar A, Mukhopadhyay BB, Chatterjee S. A comparative study of clinical features between monotypic and dual infection cases with Chikungunya virus and dengue virus in West Bengal, India. Am J Trop Med Hyg 2012; 86:720.</a></li><li><a class="nounderline abstract_t">Lee VJ, Chow A, Zheng X, et al. Simple clinical and laboratory predictors of Chikungunya versus dengue infections in adults. PLoS Negl Trop Dis 2012; 6:e1786.</a></li><li><a class="nounderline abstract_t">Mohd Zim MA, Sam IC, Omar SF, et al. Chikungunya infection in Malaysia: comparison with dengue infection in adults and predictors of persistent arthralgia. J Clin Virol 2013; 56:141.</a></li><li><a class="nounderline abstract_t">Villamil-Gómez WE, González-Camargo O, Rodriguez-Ayubi J, et al. Dengue, chikungunya and Zika co-infection in a patient from Colombia. J Infect Public Health 2016; 9:684.</a></li><li><a class="nounderline abstract_t">Waggoner JJ, Gresh L, Vargas MJ, et al. Viremia and Clinical Presentation in Nicaraguan Patients Infected With Zika Virus, Chikungunya Virus, and Dengue Virus. Clin Infect Dis 2016; 63:1584.</a></li><li><a class="nounderline abstract_t">Silva MMO, Tauro LB, Kikuti M, et al. Concomitant Transmission of Dengue, Chikungunya, and Zika Viruses in Brazil: Clinical and Epidemiological Findings From Surveillance for Acute Febrile Illness. Clin Infect Dis 2019; 69:1353.</a></li><li><a class="nounderline abstract_t">Di Paola N, Mesquita FS, Oliveira DBL, et al. An Outbreak of Human Parvovirus B19 Hidden by Dengue Fever. Clin Infect Dis 2019; 68:810.</a></li></ol></div><div id="topicVersionRevision">Topic 3025 Version 49.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22494122" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Dengue.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25230594" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Dengue.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26374064" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Dengue fever.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26374064" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Dengue fever.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14993629" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Clinical diagnosis and assessment of severity of confirmed dengue infections in Vietnamese children: is the world health organization classification system helpful?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17357044" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Severe dengue virus infection in travelers: risk factors and laboratory indicators.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20205587" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Dengue hemorrhagic fever: the sensitivity and specificity of the world health organization definition for identification of severe cases of dengue in Thailand, 1994-2005.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17467515" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Burden of symptomatic dengue infection in children at primary school in Thailand: a prospective study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17467515" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Burden of symptomatic dengue infection in children at primary school in Thailand: a prospective study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21832264" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Dengue--how best to classify it.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21832264" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Dengue--how best to classify it.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25022297" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : An evaluation of the World Health Organization's 1997 and 2009 dengue classifications in hospitalized dengue patients in Malaysia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24957540" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Comparing the usefulness of the 1997 and 2009 WHO dengue case classification: a systematic literature review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24606537" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Comparative performance of the probable case definitions of dengue by WHO (2009) and the WHO-SEAR expert group (2011).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23573291" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Implications of discordance in world health organization 1997 and 2009 dengue classifications in adult dengue.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22686428" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Dengue in travellers: applicability of the 1975-1997 and the 2009 WHO classification system of dengue fever.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22686428" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Dengue in travellers: applicability of the 1975-1997 and the 2009 WHO classification system of dengue fever.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22686428" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Dengue in travellers: applicability of the 1975-1997 and the 2009 WHO classification system of dengue fever.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16586382" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Dengue-related deaths in Puerto Rico, 1992-1996: diagnosis and clinical alarm signals.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16829301" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : The WHO dengue classification and case definitions: time for a reassessment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23563266" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : The global distribution and burden of dengue.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14903434" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Research on dengue during World War II.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12076887" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Epidemiology of inapparent and symptomatic acute dengue virus infection: a prospective study of primary school children in Kamphaeng Phet, Thailand.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7485067" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Symptoms of dengue fever in relation to host immunologic response and virus serotype, Puerto Rico, 1990-1991.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27007959" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Symptomatic Dengue in Children in 10 Asian and Latin American Countries.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23964110" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : A shorter time interval between first and second dengue infections is associated with protection from clinical illness in a school-based cohort in Thailand.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23951377" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Symptomatic versus inapparent outcome in repeat dengue virus infections is influenced by the time interval between infections and study year.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27540724" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Dengue Sentinel Traveler Surveillance: Monthly and Yearly Notification Trends among Japanese Travelers, 2006-2014.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9153369" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Dengue fever in US military personnel in Haiti.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23763775" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Travel-associated illness trends and clusters, 2000-2010.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11841702" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Evaluation of the World Health Organization standard tourniquet test and a modified tourniquet test in the diagnosis of dengue infection in Viet Nam.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3167282" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Description of the clinical picture of dengue hemorrhagic fever/dengue shock syndrome (DHF/DSS) in adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3442718" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Clinical and serologic study of Cuban children with dengue hemorrhagic fever/dengue shock syndrome (DHF/DSS).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32525532" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Prevalence and clinical manifestations of dengue in older patients in Bangkok Hospital for Tropical Diseases, Thailand.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27567120" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Facial Puffiness in a Returning Traveler From Puerto Rico: Chikungunya, Dengue Fever, or Zika Virus?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16135837" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Dengue in travelers.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9237695" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Early clinical and laboratory indicators of acute dengue illness.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18803612" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Clinical and laboratory features that distinguish dengue from other febrile illnesses in endemic populations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17993365" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Dengue.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18335069" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Decision tree algorithms predict the diagnosis and outcome of dengue fever in the early phase of illness.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16687699" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Dengue hemorrhagic fever patients with acute abdomen: clinical experience of 14 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17414388" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Natural history of plasma leakage in dengue hemorrhagic fever: a serial ultrasonographic study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30549307" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Ultrasound Assessment of Hepatobiliary and Splenic Changes in Patients With Dengue and Warning Signs During the Acute and Recovery Phases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11996683" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Hospital-based diagnosis of hemorrhagic fever, encephalitis, and hepatitis in Cambodian children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10744091" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Neurological manifestations of dengue infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23948177" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Neurological complications of dengue virus infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24510171" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Unusual and rare manifestations of dengue during a dengue outbreak in a tertiary care hospital in South India.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25220113" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Neurological manifestations of dengue infection: a review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24474020" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Dengue infection in children and adolescents: clinical profile in a reference hospital in northeast Brazil.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31971031" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Severe dengue and liver involvement: an overview and review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16524594" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Neurological manifestations of dengue virus infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22357720" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Central nervous system involvement in dengue: a study in fatal cases from a dengue endemic area.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25253749" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Neurologic complications in dengue virus infection: a prospective cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29530869" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Risk of stroke in patients with dengue fever: a population-based cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21946658" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Cardiac function in Vietnamese patients with different dengue severity grades.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23784923" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Evaluation of cardiac involvement during dengue viral infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24710495" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Cardiovascular manifestations of the emerging dengue pandemic.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26226658" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Evaluation of Cardiac Involvement in Children with Dengue by Serial Echocardiographic Studies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20032806" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Heart and skeletal muscle are targets of dengue virus infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19346394" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Clinical characteristics, risk factors, and outcomes in adults experiencing dengue hemorrhagic fever complicated with acute renal failure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20362302" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Outcome of dengue hemorrhagic fever-caused acute kidney injury in Thai children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20702532" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Acute kidney injury in tropical acute febrile illness in a tertiary care centre--RIFLE criteria validation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25349377" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Clinical features of and risk factors for rhabdomyolysis among adult patients with dengue virus infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32346163" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : A prospective 3 year study of clinical spectrum and outcome of dengue fever in ICU from a tertiary care hospital in North India.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16494756" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Ophthalmic complications of dengue.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22789140" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Hemophagocytosis in dengue: comprehensive report of six cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24452132" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Fatal hemophagocytic lymphohistiocytosis associated with locally acquired dengue virus infection - New Mexico and Texas, 2012.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26338309" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Risk factors for concurrent bacteremia in adult patients with dengue.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27448105" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Bacterial coinfections in dengue virus disease: what we know and what is still obscure about an emerging concern.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31188423" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Dengue Infection Complicated by Hemophagocytic Lymphohistiocytosis: Experiences From 180 Patients With Severe Dengue.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31353429" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Severe Dengue and Associated Hemophagocytic Lymphohistiocytosis in PICU.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Dengue patients at the Children’s Hospital, Bangkok: 1995-1999 review</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20824173" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Multi-country evaluation of the sensitivity and specificity of two commercially-available NS1 ELISA assays for dengue diagnosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26984143" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Performance of Dengue Diagnostic Tests in a Single-Specimen Diagnostic Algorithm.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28480265" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Clinical Utility of the Nonstructural 1 Antigen Rapid Diagnostic Test in the Management of Dengue in Returning Travelers With Fever.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31194720" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Dengue and Zika Virus Diagnostic Testing for Patients with a Clinically Compatible Illness and Risk for Infection with Both Viruses.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29300876" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Impact of Dengue Vaccination on Serological Diagnosis: Insights From Phase III Dengue Vaccine Efficacy Trials.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15073678" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Localization of dengue virus in naturally infected human tissues, by immunohistochemistry and in situ hybridization.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22492160" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : A comparative study of clinical features between monotypic and dual infection cases with Chikungunya virus and dengue virus in West Bengal, India.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23029573" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Simple clinical and laboratory predictors of Chikungunya versus dengue infections in adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23201456" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Chikungunya infection in Malaysia: comparison with dengue infection in adults and predictors of persistent arthralgia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26754201" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : Dengue, chikungunya and Zika co-infection in a patient from Colombia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27578819" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Viremia and Clinical Presentation in Nicaraguan Patients Infected With Zika Virus, Chikungunya Virus, and Dengue Virus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30561554" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : Concomitant Transmission of Dengue, Chikungunya, and Zika Viruses in Brazil: Clinical and Epidemiological Findings From Surveillance for Acute Febrile Illness.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30304533" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : An Outbreak of Human Parvovirus B19 Hidden by Dengue Fever.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
